Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ocular Surface Inflammatory Process (OSIP) refers to a set of biological events rather than a single molecule or receptor. It is not a specific molecular entity but rather an umbrella term for multiple pathways and mediators. While OSIP is not a single disease state, therapeutic strategies target the inflammatory processes and mediators involved.
Not applicable as this is not a single molecule or receptor. Mechanisms vary depending on the specific component targeted, e.g., suppression of proinflammatory gene expression by corticosteroids; inhibition of calcineurin-mediated T-cell activation by cyclosporine A; blocking LFA-1/ICAM interaction by lifitegrast.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular Surface Inflammatory Process (OSIP).